Rubius Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
19 Jul 2022	Form 3: Schaffert Susanne, Director No securities owned
16 Aug 2021	Form 3: Appelhans Dannielle, Chief Operating Officer No securities owned
08 Oct 2020	Form 3: Carmona Jose, Chief Financial Officer No securities owned
28 Jan 2020	Form 3: Turka Laurence A., Chief Scientific Officer No securities owned
13 Jan 2020	Form 3: Coughlin Christina M., Chief Medical Officer No securities owned
26 Dec 2019	Form 3: Prener Anne, Director No securities owned
20 Nov 2019	Form 3: Keson-Brookes Maiken, CLO & Corp. Secretary No securities owned
27 Mar 2019	Form 3: Holles Natalie C., Director No securities owned
17 Jul 2018	Form 3: Flagship Ventures Fund Iv General Partner Llc, Director and 8 others Holds 5,000,000 shares of Common Stock
17 Jul 2018	Form 3: Symonds Jonathan, Director
17 Jul 2018	Form 3: Cuss Francis M, Director
17 Jul 2018	Form 3: Nissen Torben Straight, President Holds 1,860,000 shares of Common Stock
17 Jul 2018	Form 3: Epstein David R, Director Holds 4,980,453 shares of Common Stock
17 Jul 2018	Form 3: Pomerantz Roger, Director
17 Jul 2018	Form 3: Langer Robert, Director
17 Jul 2018	Form 3: Cagnoni Pablo J, Director
17 Jul 2018	Form 3: Sohn Catherine A., Director
17 Jul 2018	Form 3: Carpenter Christopher L., Chief Medical Officer
17 Jul 2018	Form 3: Rosenblatt Michael, Director
17 Jul 2018	Form 3: Oh Andrew M., Chief Financial Officer

Comments